HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suberoylanilide hydroxamic acid induces hypersensitivity to radiation therapy in acute myelogenous leukemia cells expressing constitutively active FLT3 mutants.

Abstract
Histone deacetylase inhibitors (HDIs) have shown promise as candidate radiosensitizer for many types of cancers. However, the mechanisms of action are not well understood, and whether they could have clinical impact on radiotherapy for leukemia is unclear. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) can increase radiosensitivity of acute myeloid leukemia (AML) cells through posttranslational modification of Rad51 protein responses and selective inhibition of the homology-directed repair (HDR) pathway. Our data also showed that AML cells with mutant, constitutively active FMS-like tyrosine kinase-3 (FLT3) were more radiation sensitive, caused by compromised non-homologous end joining (NHEJ) repair. Furthermore, SAHA-induced radiosensitization were enhanced in AML cells with expression of these FLT3 mutants. The results of this study suggest that SAHA, a recently approved HDI in clinical trials, may act as a candidate component for novel conditioning regimens to improve efficacy for AML patients undergoing radiotherapy and chemotherapy.
AuthorsXufeng Chen, Eric H Radany, Patty Wong, Shenglin Ma, Kan Wu, Bing Wang, Jeffrey Y C Wong
JournalPloS one (PLoS One) Vol. 8 Issue 12 Pg. e84515 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24367670 (Publication Type: Journal Article)
Chemical References
  • Hydroxamic Acids
  • Vorinostat
  • fms-Like Tyrosine Kinase 3
  • Protein Kinase C
  • Rad51 Recombinase
Topics
  • Cell Line, Tumor
  • DNA Damage
  • DNA Repair (drug effects, radiation effects)
  • Enzyme Activation (drug effects, radiation effects)
  • Gene Expression Regulation, Neoplastic (drug effects, radiation effects)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Leukemia, Myeloid, Acute (drug therapy, genetics, pathology, radiotherapy)
  • Mutation
  • Protein Kinase C (metabolism)
  • Rad51 Recombinase (metabolism)
  • Radiation Tolerance (drug effects)
  • Vorinostat
  • fms-Like Tyrosine Kinase 3 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: